Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice

Ataxia-telangiectasia mutated (ATM) is a cell cycle checkpoint kinase that upon activation by DNA damage leads to cell cycle arrest and DNA repair or apoptosis. The absence of Atm or the occurrence of loss-of-function mutations in Atm predisposes to tumorigenesis. MAPK7 has been implicated in numero...

Descripción completa

Detalles Bibliográficos
Autores: Granados Jaén, Alba, Angulo Ibáñez, María, Rovira Clavé, Xavier, Vasquez Gamez, Celina Paola, Soriano Zaragoza, Francesc X. (Francesc Xavier), Reina del Pozo, Manuel, Espel Masferrer, Enric
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/107569
Acceso en línea:https://hdl.handle.net/2445/107569
Access Level:acceso abierto
Palabra clave:Proteïnes quinases
Reparació de l'ADN
Limfomes
Protein kinases
DNA repair
Lymphomas
Descripción
Sumario:Ataxia-telangiectasia mutated (ATM) is a cell cycle checkpoint kinase that upon activation by DNA damage leads to cell cycle arrest and DNA repair or apoptosis. The absence of Atm or the occurrence of loss-of-function mutations in Atm predisposes to tumorigenesis. MAPK7 has been implicated in numerous types of cancer with pro-survival and pro-growth roles in tumor cells, but its functional relation with tumor suppressors is not clear. In this study, we show that absence of MAPK7 delays death due to spontaneous tumor development in Atm-/- mice. Compared with Atm-/- thymocytes, Mapk7-/-Atm-/- thymocytes exhibited an improved response to DNA damage (increased phosphorylation of H2AX) and a restored apoptotic response after treatment of mice with ionizing radiation. These findings define an antagonistic function of ATM and MAPK7 in the thymocyte response to DNA damage, and suggest that the lack of MAPK7 inhibits thymic lymphoma growth in Atm-/- mice by partially restoring the DNA damage response in thymocytes.